RECRUITING

Ventricular Tachycardia Mechanisms

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart tissue to understand how these arrhythmias occur, and hopefully identify areas that might lead to ventricular arrhythmias. The hope is that studying this might be able to improve outcomes during ventricular tachycardia (VT) ablations.

Official Title

Ventricular Tachycardia Substrate Mechanisms Revealed by Local Repolarization and Conduction Parameters

Quick Facts

Study Start:2022-10-25
Study Completion:2025-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05478213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of ischemic cardiomyopathy
  2. * Single or dual chamber implantable cardioverter-defibrillator (ICD)
  1. * Non-Ischemic cardiomyopathy
  2. * Contraindication to catheter ablation
  3. * Severe peripheral arterial disease or medical condition that prohibit arterial access
  4. * Ventricular tachycardia (VT) or sudden cardiac arrest (SCA) within 30 days of acute coronary syndrome or within 90 days of coronary revascularization

Contacts and Locations

Study Contact

Neal Bhatia, MD
CONTACT
404-686-7878
neal.kumar.bhatia@emory.edu

Principal Investigator

Neal Bhatia, MD
PRINCIPAL_INVESTIGATOR
Emory University

Study Locations (Sites)

Emory University Hospital Midtown
Atlanta, Georgia, 30308
United States
Emory Clinic
Atlanta, Georgia, 30322
United States
Emory University Hospital
Atlanta, Georgia, 30322
United States

Collaborators and Investigators

Sponsor: Emory University

  • Neal Bhatia, MD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-25
Study Completion Date2025-03

Study Record Updates

Study Start Date2022-10-25
Study Completion Date2025-03

Terms related to this study

Keywords Provided by Researchers

  • Ventricular tachycardia ablation

Additional Relevant MeSH Terms

  • Ventricular Tachycardia